Cargando…

Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension

BACKGROUND: The management of chronic diseases is a continuing challenge for health care systems and patients. OBJECTIVE: To assess the effect of a pharmacist-specific chronic diseases management incentive plan (the Comprehensive Annual Care Plan [CACP]) implemented by the government of Alberta (Can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zongo, Arsène, Simpson, Scot, Johnson, Jeffrey A, Eurich, Dean T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390929/ https://www.ncbi.nlm.nih.gov/pubmed/33769856 http://dx.doi.org/10.18553/jmcp.2021.27.4.426

Ejemplares similares

Change in Trajectories of Adherence to Lipid‐Lowering Drugs Following Non‐Fatal Acute Coronary Syndrome or Stroke
por: Zongo, Arsène, et al.
Publicado: (2019)

Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study
por: Zongo, Arsène, et al.
Publicado: (2019)

Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada
por: Necyk, Candace, et al.
Publicado: (2021)

The Darkening Cloud of Diabetes: Do trends in cardiovascular risk management provide a silver lining?
por: Eurich, Dean T., et al.
Publicado: (2008)

Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021)

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
por: Sharma, Vishal, et al.
Publicado: (2020)

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study
por: Sharma, Vishal, et al.
Publicado: (2019)

Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
por: Zongo, Arsene, et al.
Publicado: (2021)

Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
por: Alkabbani, Wajd, et al.
Publicado: (2021)

Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus
por: Alkabbani, Wajd, et al.
Publicado: (2022)

Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients
por: Abughosh, Susan M., et al.
Publicado: (2004)

Are Lipid-Lowering and Antihypertensive Medications Used as Complements to Heart-Healthy Diets? A Scoping Review
por: Desjardins, Clémence, et al.
Publicado: (2023)

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
por: Dierkes, Jutta, et al.
Publicado: (2007)

A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study
por: Evans, Charity D, et al.
Publicado: (2010)

Working towards a better understanding of type 2 diabetes care organization with First Nations communities: a qualitative assessment
por: Wozniak, Lisa A., et al.
Publicado: (2020)

Pharmacists’ chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization
por: Makhinova, Tatiana, et al.
Publicado: (2023)

Predicting falls-related admissions in older adults in Alberta, Canada: a machine-learning falls prevention tool developed using population administrative health data
por: Sharma, Vishal, et al.
Publicado: (2023)

Chronic disease surveillance in Alberta’s tomorrow project using administrative health data
por: Ye, Ming, et al.
Publicado: (2021)

Pleiotropic and Lipid–lowering Effects of Statins in Hypertension
por: Kamberi, Lulzim Selim, et al.
Publicado: (2012)

Comprehensive pharmacy review for NAPLEX /
Publicado: (2013)

Retrospective Observational Assessment of Statin Adherence Among Subjects Patronizing Different Types of Community Pharmacies in Canada
por: Evans, Charity D., et al.
Publicado: (2009)

Key Role of Drug Shops and Pharmacies for Family Planning in Urban Nigeria and Kenya
por: Corroon, Meghan, et al.
Publicado: (2016)

Adopting and implementing an innovative model to organize diabetes care within First Nations communities: A qualitative assessment
por: Wozniak, Lisa A., et al.
Publicado: (2021)

Need for Coursework in Pharmacy Curricula on Managed Care Pharmacy
por: Johnson, Robert C.
Publicado: (2010)

Comparison of Mail-Order With Community Pharmacy in Plan Sponsor Cost and Member Cost in Two Large Pharmacy Benefit Plans
por: Johnsrud, Michael, et al.
Publicado: (2007)

Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
por: Levine, A. Alex, et al.
Publicado: (2023)

Employer and Plan Sponsor Views on Pharmacy Reimbursement
por: Stull, Michael, et al.
Publicado: (2020)

The UK Pharmacy Care Plan service: Description, recruitment and initial views on a new community pharmacy intervention
por: Twigg, Michael J., et al.
Publicado: (2017)

Development and Validation of a Machine Learning Model to Estimate Risk of Adverse Outcomes Within 30 Days of Opioid Dispensation
por: Sharma, Vishal, et al.
Publicado: (2022)

Exploring the intentions of pharmacy students towards pharmacy ownership by using theory of planned behaviour
por: Khan, Muhammad Umair, et al.
Publicado: (2016)

Pharmacy Students Teaching Prescribers Strategies to Lower Prescription Drug Costs for Underserved Patients
por: Stebbins, Marilyn R., et al.
Publicado: (2013)

Improving Adherence to Lipid-Lowering Therapy in a Community Pharmacy Intervention Program: A Cost-Effectiveness Analysis
por: Vegter, Stefan, et al.
Publicado: (2014)

Lipid-lowering drugs (statins) and peripheral neuropathy
por: Emad, Mohammadreza, et al.
Publicado: (2018)

Anti-flavivirus Properties of Lipid-Lowering Drugs
por: Farfan-Morales, Carlos Noe, et al.
Publicado: (2021)

Drugs and Pharmacy in Prints
por: Crellin, J. K.
Publicado: (1969)

Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs
por: Nilsson, Peter M., et al.
Publicado: (2010)

The association of lipid-lowering therapy and blood pressure control among outpatients with hypertension at the Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia
por: Abebe, Rahel Belete, et al.
Publicado: (2023)

The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
por: Soprovich, Allison, et al.
Publicado: (2019)

An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
por: Soprovich, Allison, et al.
Publicado: (2017)

Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice
por: Fuentes, Andrea V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_133u11v6b5cgmrp1sekhgds3h3